Immunity to Toxoplasma gondii

Current Opinion in Immunology

Volumn 5, Issue 4, 1993, Pages 532-537

  Subauste, C S ^a   Remington, J S ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

APC antigen presenting cell; CMV cytomegalovirus; ConA concanavalin A; CSF cerebrospinal fluid; HSP heat shock protein; IFN interferon; IL interleukin; LAK lymphokine activated killer; mAb monoclonal antibody; muLV murine leukemia virus; NK natural killer; RNI reactive nitrogen intermediate; SCID severe combined immunodeficient; TE toxoplasmic encephalitis; TNF tumor necrosis factor

Indexed keywords

ANTIGEN; CYTOKINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; IMMUNITY; INFECTION; LYMPHOCYTE; NONHUMAN; REVIEW; SEROLOGY; T LYMPHOCYTE SUBPOPULATION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMAL; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HUMAN; IMMUNITY; MICE; MOUTH MUCOSA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTE SUBSETS; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, ANIMAL;

EID: 0027220772     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/0952-7915(93)90034-P     Document Type: Article

References (51)

1. Laminin Enhances Binding of Toxoplasma gondii Tachyzoites to J774 Murine Macrophage Cells
2. Virulent Strains of Toxoplasma gondii Comprise a Single Clonal Lineage
3. Isoenzyme Analysis of 35 Toxoplasma gondii Isolates and the Biological and Epidemiological Implications
4. Biology of Toxoplasma gondii
5. + T Cells in Mice
6. + T Lymphocytes in IFN-γ Production and Protective Immunity Induced by Attenuated Toxoplasma gondii Vaccine
7. +) T Lymphocytes Prevents Development of Resistance to Toxoplasma gondii in Mice
8. + T Lymphocytes is Required to Reactivate Chronic Infection with Toxoplasma gondii
9. Opportunistic Infections and Retrovirus-induced Immunodeficiency: Studies of Acute and Chronic Infections with Toxoplasma gondii in Mice Infected with LP-BM5 Murine Leukemia Viruses
10. Toxoplasma gondii: Induction of Toxoplasmmc Encephalitis in Mice with Chronic Infection by Inoculation of a Murine Leukemia Virus Inducing Immunodeficiency
11. + T Cells but not Inhibition of the Protective Activity of IFN-γ Prevents Cure of Toxoplasmosis Mediated by Drug Therapy in Mice
12. + Immune T Cells Against Toxoplasmosis in Mice
13. + Cytotoxic T Lymphocytes Lyse Toxoplasma gondii-infected Cells
14. + T Cells from Mice Vaccinated Against Toxoplasma gondii are Cytotoxic for Parasite-infected or Antigen-pulsed Host Cells
15. + Cytotoxic Cells
16. Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii.
17. + T Cells are Cytotoxic Against Toxoplasma gondii-infected Peritoneal Macrophages
18. Protection of Mice and Nude Rats Against Toxoplasmosis by a Multiple Antigenic Peptide Construction Derived from Toxoplasma gondii P30 Antigen
19. Antigen Presentation by Toxoplasma-infected Cells: Antigen Entry through Cell Membrane Fusion
20. Cytotoxic T Lymphocytes Against a Soluble Protein
21. Bone Marrow Macrophages Process Exogenous Toxoplasma gondii Polypeptides for Recognition by Parasite-specific Cytolytic T Lymphocytes
22. Induction of Antigen-specific Suppressor T Cells During Acute Infection with Toxoplasma gondii
23. Cytomegalovirusinduced Reactivation of Toxoplasma gondii Pneumonia in Mice: Lung Lymphocyte Phenotypes and Suppressor Function
24. Phenotypic Profile and Functional Characteristics of Human γδ T Cells During Acute Toxoplasmosis
25. Lymphocytes Bearing the γδ T-cell Receptor in Acute Toxoplasmosis
26. Induction of Heat Shock Protein Closely Correlates with Protection Against Toxoplasma gondii Infection
27. In Vivo Recombinant Interleukin-2 Administration Enhances Survival Against a Lethal Challenge with Toxoplasma gondii
28. Human Lymphokine activated Killer Cells are Cytotoxic Against Cells Infected with Toxoplasma gondii
29. Enhanced Antimetastatic Activity of Lymphokine-activated Killer Cells Purified and Expanded by their Adherence to Plastic
30. Human Platelet-mediated Cytotoxicity Against Toxoplasma gondii: Role of Thromboxane
31. Cytotoxic Activity Of 13-hydroxyoctadecadienoic Acid Against Toxoplasma gondii
32. Mucosal and Systemic Cellular Immune Responses Induced by Toxoplasma gondii Antigens in Cyst Orally Infected Mice
33. Secretory IgA Specfic for Toxoplasma gondii
34. Human Toxoplasma gondii-specific Secretory Immunoglobulin A Reduces T. gondii Infection of Enterocytes in Vitro
35. Toxoplasma gondii The Role Of a 30-kDa Surface Protein in Host Cell Invasion
36. Cytokines, Toxoplasma and Intracellular Parasitism
37. Interferon-γ: The Major Mediator of Resistance Against Toxoplasma gondii
38. Kinetics of Cytokine mRNA Production in the Brains of Mice with Progressive Toxoplasmic Encephalitis
39. Role of TNF and IL-1 in Infections with Toxoplasma gondii
40. Expression of Major Histocompatibility Complex Class II Antigens and Levels of Interferon-γ, Tumour Necrosis Factor, Interleukin-6 in Cerebrospinal Fluid and Serum in Toxoplasma gondii-infected SCID and Immunocompetent C.B.-17
41. Effect of Recombinant Tumor Necrosis Factor on Acute Infection in Mice with Toxoplasma gondii or Trypanosoma cruzi
42. A Protective Role for Endogenous Tumor Necrosis Factor In Toxoplasma gondii Infection
43. Role of Tumour Necrosis Factor in Chronic Murine Toxoplasma gondii Encephalitis
44. A Gene(s) Within the H-2D Region Determines the Development of Toxoplasmic Encephalitis
45. Polymorphisms in the Tumor Necrosis Factor α (TNF-α) Gene Correlate with Murine Resistance to Development of Toxoplasmic Encephalitis and with levels of TNF-α mRNA in Infected Brain Tissue
46. Endogenous Tumor Necrosis Factor α is Required for Enhanced Antimicrobial Activity Against Toxoplasma gondii and Listeria monocytogenes in Recombinant γ Interferon-treated Mice
47. IFN-γ-induced Larginine-dependent Toxoplasmastatic Activity in Murine Peritoneal Macrophages is Mediated by Endogenous Tumor Necrosis Factor-α
48. IL-10 Inhibits Parasite Killing and Nitrogen Oxide Production by IFN-γ activated Macrophages
49. In Vitro Effects of Interleukin-4 on Interferon-γ-induced Macrophage Activation
50. SCID Mouse Models of Acute and Relapsing Chronic Toxoplasma gondii Infections
51. Expression, Characterization, and Serologic Reactivity of Recombinant Surface Antigen p22 of Toxoplasma gondii